Altavo raised €5.0M in a Series A round in Feb 2024. The company is based in Dresden, Germany. Investors in the round: bm-t Beteiligungsmanagement Thüringen GmbH, High-Tech Gründerfonds (HTGF), Novalis Biotech and 4 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €5.0M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
